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Abstract: The ion-step measuring method was used to determine heparin 
concentrations in PBS and blood plasma. Heparin is a sulphated polysaccharide 
which is clinically used as a drug to prevent the clotting of blood. The 
measuring method is based on detection of changes in charge density in a 
porous membrane which is deposited on the gate of an ISFET. Protamine 
was used as affinity ligand in the membrane. In PBS a linear relation was 
found between the heparin concentration and the ISFET response. The 
incubation time was reduced from 18 h to 15 min by increasing the porosity 
of the membrane. The results of the measurements in blood plasma show a 
significant nonspecific binding of plasma components in the membrane. 
Suggestions are given to prevent this nonspecific adsorption. The results 
described in this paper show a detection limit for the ion-step measuring 
method of at least 5 k lo-” Mel/l which is promising for future practical 
applications. 
Keywords: biosensor, ISFET, heparin, protamine. 
1. INTRODUCTION 
In 1990 a new measuring method was introduced 
to detect changes in charge density in a porous 
membrane deposited on top of an ISFET 
(Schasfoort et al., 1990). With this new method 
it is possible to determine concentrations of large 
charged molecules such as proteins Schasfoort 
*Author to whom correspondence should be addressed. 
et al. already showed the possibility of determining 
aHSA concentrations by using HSA as affinity 
ligand in the membrane. 
A new research project has been started to 
develop a simple sensor system based on the ion- 
step measuring method. This project is aimed at 
the determination of heparin concentrations in 
blood as a first practical application of the ion- 
step measuring method (van Kerkhof et al., 
1992). 
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Heparin 
Heparin is a sulphated glycosaminoglycan (GAG) 
found in liver, lung and other tissues which has 
several pharmacological properties (Nader and 
Dietrich, 1989). The property of heparin which 
has attracted most attention and resulted in its 
widespread use is its ability to prolong the clotting 
time of blood by preventing the formation of 
fibrin. This anticoagulant activity of heparin is 
used in vascular surgery and in treatment of 
postoperative thrombosis and embolism. 
The coagulation enzyme thrombin which con- 
verts fibrinogen into fibrin (the insoluble basis 
of a blood clot), is inhibited by antithrombin 
III, another plasma protein. Heparin binds to 
antithrombin III and produces a conformational 
change, thereby converting antithrombin III from 
a progressive, slow inhibitor to a very rapid 
inhibitor. After binding of this antithrombin III- 
heparin complex to a thrombin molecule, heparin 
dissociates from the complex and is reusable 
(Bjork et al., 1989; Rosenberg, 1987). 
Heparin is one of a large variety of drugs 
extracted from natural sources whose activity 
cannot be adequately described or predicted by 
chemical and physical methods. In spite of the 
enormous advances made in recent years of 
the knowledge of the chemical basis for the 
anticoagulant activity of heparin (Petitou, 1989; 
Casu, 1989), the assessment of heparin for quality 
control purposes by manufacturers and for dosage 
by clinicians is still made in units of biological 
activity. Quantity of heparin is expressed in units. 
The heparin unit is defined as the anticoagulant 
activity of l/130 mg of the International Standard 
heparin preparation (Barrowcliffe, 1989). Unlike 
other drugs in other systems, the activity for a 
given commercial preparation relative to the 
International Standard heparin preparation 
changes with the method of comparison in 
coagulation tests. Hence the values will not 
necessarily be the same for any two preparations 
when compared by different procedures. Equival- 
ence figures can be expressed in units qualified 
by the name of the procedure but because this 
means a number of different values for a given 
preparation, the result can be confusing. 
A heparin treatment must result in heparin 
levels in the blood that are sufficient to control 
thrombosis and yet avoid undue risk of bleeding. 
The antithrombotic effect and the risk of bleeding 
varies, however, not only with the dose but also 
with the individual response. This variation in 
response to heparin calls for an individualization 
of the heparin dose regimen and a careful clinical 
monitoring by laboratory tests (Abildgaard, 
1989). The activated partial thromboplastin time 
(AP’IT) is the most widely used clinical laboratory 
test for heparin monitoring. In this test, the 
clotting time is measured of a plasma sample to 
which an initiator of the bloodclotting process is 
added. In the presence of the initiator, coagu- 
lation is greatly accelerated and anticoagulant 
activity can then be measured by the delay of 
appearance of a clot, with clotting times in the 
order of minutes. 
Commercial preparations of heparin are hetero- 
geneous, and their components have molecular 
weights ranging from 3 000 to 30000 (mean 
15 000). The primary chemical structure of hep- 
arin consists of alternating hexuronic acid (D- 
glucuronic or L-iduronic) and D-glucosamine 
residues, which are variably sulphated at amino 
and hydroxyl groups (Casu, 1989). At physiologi- 
cal pH values the three acid functional groups 
in heparin are fully dissociated to yield -OSO,, 
-NHSO, and -COO- groups thus resulting in 
a highly negatively charged heparin molecule. 
The ion-step measuring method 
The device used in this measuring method consists 
of a porous membrane of polystyrene beads 
linked together with agarose, which is deposited 
on the gate of an ISFET (Fig. 1). An affinity 
ligand can be immobilized in the membrane via 
physical adsorption or covalent binding. The 
charged groups of the polystyrene beads together 
with the charged groups of the affinity ligand, 
result in a net charge density c, in the membrane 
calomel reference 
I-J 
electrode 
To, 0 
Membrane with fixed 
charge density 
502 
ISFET 
Fig. 1. The device. 
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which is pH dependent in case the charged 
groups are titratable. If the sensor is actuated by 
a stepwise change of the electrolyte concentration 
c, at t = to (Fig. 2A), the ISFET shows a 
transient response of which the amplitude AV is 
a function of the net charge density in the 
membrane (Fig. 2B). The ISFET response is 
positive if c, is negative and vice versa. The 
origin of the response is investigated in detail by 
Eijkel ef al. (1992). Here we would like to 
confine ourselves to a short description of the 
mechanism. 
When a layer of protein molecules is in 
thermodynamical equilibrium with a solution with 
a certain pH and ion concentration, the ions in 
the solution and in the protein layer will be 
distributed according to the Donnan ratio (the 
ratio of the ion activities in the two phases). As 
a result, there will exist an electrical potential 
difference between the protein layer and the 
bulk solution which is known as the Donnan 
potential. 
The dissociation of titratable groups of a 
protein molecule is influenced by the electrolyte 
concentration. A positively charged protein will 
contain more bound protons per molecule at 
higher electrolyte concentrations and a negatively 
0 A 
Fig. 2. A: Electrolyte concentration c, as a function of 
time. B: ISFET response as a function of time for c, 
is negative. 
charged protein will contain less bound protons 
per molecule at higher concentrations. 
When the membrane of polystyrene beads is in 
thermodynamical equilibrium, Donnan potentials 
exist at the pore walls of the porous membrane, 
where the protein is immobilized. At high charge 
densities the resulting fields can extend to the 
pore centres, and consequently the membrane 
itself will have a potential with respect to the 
bulk solution. 
As a result of a stepwise increase in electrolyte 
concentration, the Donnan potentials of the 
protein layer will diminish, thereby also dimin- 
ishing the potential of the membrane itself versus 
the bulk solution. Furthermore, protons will be 
released by negatively charged protein molecules 
or taken up by positively charged protein mol- 
ecules because the dissociation is changed with 
the ion concentration. The underlying ISFET 
measures the change in the potential of the 
membrane with respect to the bulk solution as 
well as the pH effect of the protons released or 
taken up. The pH effect of the protons is 
responsible for almost the entire response on an 
ion-step. 
Measuring heparin concentrations with the ion- 
step measuring method 
In clinical practice a heparin treatment is moni- 
tored by coagulation tests which determine the 
biological activity of heparin. It is shown that 
only about one third of a commercial heparin 
preparation has anticoagulant activity (Hirsch, 
1991). The relevance of in vitro heparin assays 
(measuring the activity) to in vivo events is 
however still unclear. Other studies have shown 
that extra anticoagulant activity of injected hep- 
arin is generated in vivo (Levy and Jaques, 1978). 
In these studies the total absolute amount of 
heparin in plasma is measured instead of the 
biological activity (Jaques ef al., 1990). 
Without taking part in the discussion about 
how to monitor a heparin treatment, the present 
paper describes the possibility of measuring 
heparin concentrations (total amount) with the 
ion- step measuring method. The method can 
probably also be used to measure biological 
activity of heparin by using another affinity ligand 
binding to another analyte, which interaction 
depends on the biological activity of heparin 
(e.g. thrombin to bind antithrombin III). This 
will be a subject for future research. 
J. C. van Kerkhof et al. 
The range which is of physiological importance 
for monitoring is O-1-1.0 units/ml. The heparin 
we used in our experiments was a commercial 
heparin solution for clinical application. The 
concentration was defined in anticoagulant 
activity units/ml. The results of our experiments 
are therefore given as a function of this concen- 
tration. 
To determine heparin concentrations prota- 
mine has been chosen as an affinity ligand. 
Protamine is clinically used to neutralize heparin 
and to counteract its anticoagulant effects. The 
protamines are a family of basic proteins which 
typically contain 22 arginines out of 32 amino 
acids (MW +4000). It is found that the interaction 
of protamine and heparin consists of 1:l pairing 
of anionic heparin sites with cationic protamine 
sites (Cundall ef al., 1982). 
The use of the positively charged protamine 
as affinity ligand for the negatively charged 
heparin will result in a substantial change in 
charge density in the membrane which is very 
beneficial when using the ion-step measuring 
method. Therefore, the protamine-heparin couple 
seems to be a good realistic example for the 
development of the first sensor system based on 
the ion-step measuring method. The protocol to 
realize the calibration curve of the sensor response 
as a function of heparin concentration is as 
follows: 
Immobilize protamine in the porous mem- 
brane .
Calibrate the device by measuring the 
response to an ion-step. 
Expose the device to a known heparin 
concentration for a certain incubation time. 
Determine the response to an ion-step. 
Determine the shift in response with respect 
to the calibration. 
Repeat the previous steps for different 
heparin concentrations. 
Plot the shift in response as a function of 
heparin concentration. 
2. MATERIALS AND METHODS 
The measurement set-up consists of a computer- 
controlled flow through system in which the pH 
can be varied by mixing two buffers with variable 
ratio. The electrolyte concentration at the surface 
of the membrane-covered ISFET can be changed 
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within 50 msec from a 10 mM KC1 to a 50 mM 
KC1 solution by switching a valve. For some of 
the experiments the 10 mM KC1 solution was 
buffered with a mixture of O-2 mM citric acid 
and 0.5 mM TRIS to vary the pH between 4 and 
9 while the 50 mM KC1 solution was not buffered. 
Other experiments were performed with 10 and 
50 mM KC1 solutions which were both buffered 
with respectively 0.5 and O-2 mM HEPES (pH 
7.55). 
The responses of the Ta205-ISFETs were 
measured with a source and drain follower 
(Bergveld, 1981) and recorded with a Nicolet 
310 digital storage oscilloscope. 
The membranes were made according to the 
process described by Schasfoort ef al. (1990). A 
0.25% agarose solution (low IEE, zero M,, 
Biorad) was mixed 1:l with a suspension of 
polystyrene beads (2.5% solids-Latex, Polysci- 
ences inc.) at 40-50°C and portions of 3 microlitres 
were cast on the ISFETs. After overnight drying 
at 4°C and a temperature step of 55°C (for one 
hour), membranes with a thickness of about 
10-15 micron (in dry condition) resulted. An 
additional step with respect to the original process 
was ultrasonication of the mixture for l-2 min 
before casting it on the ISFETs. This resulted in 
more homogeneous membranes as is shown on 
the SEM-photographs in Fig. 3. 
Protamine sulphate (grade X, from salmon) 
was purchased from Sigma and heparin from 
Organon Teknika (Thromboliquine@, 5 ml 
ampoules containing 25 000 units). Protamine 
was immobilized in the membrane by physical 
adsorption or by covalent binding. In the case 
of immobilization by physical adsorption, ISFETs 
with membranes were exposed to a solution of 
O-1 mg ml-l protamine sulphate in phosphate 
buffered saline (PBS) for 1-17 h. In the case of 
immobilization by covalent binding, polystyrene 
beads with functional amino groups were washed 
in a buffer solution and subsequently the amino 
groups were activated by glutaraldehyde. Next, 
the beads were washed again and exposed to a 
solution of 0.25 mg ml-’ protamine sulphate for 
about 4-5 h. After washing, the beads were used 
to make membranes. 
For the experiments in blood plasma, titrated 
normal plasma was used which was a gratefully 
accepted gift from the laboratory of the ‘Medisch 
Spectrum Twente’ hospital. Small amounts of 
the concentrated heparin solution were added to 
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Fig. 4. Top curve: typical ion-step response of an 
ISFET with a membrane of 0.12 pm beads without 
coupled proteins. Bottom curve: typical ion-step 
response of an ISFET with a membrane of 0.12 pm 
beads with adsorbed protamine. 
(b) 
Fig. 3. (a) SEMphotograph of a membrane of 0.12 pm 
beads without ultrasonication of the membrane mixture. 
(b) SEM photograph of a membrane of 0.12 pm beads 
after ultrasonication of the membrane mixture. 
the titrated normal plasma to obtain plasma 
samples with different heparin concentrations. 
3. RESULTS 
A typical ion-step response of an ISFET provided 
with a membrane of O-12 micron polystyrene 
beads is given in Fig. 4. In this case the 10 mM 
KC1 and the 50 mM KC1 solutions were both 
buffered at pH 7.3. The top curve represents a 
typical ion-step response of an ISFET with a 
bare membrane without immobilized proteins. 
The negative surface charge on the beads (and 
possibly the agarose) result in a positive response. 
To immobilize the protamine, the device was 
incubated for 15 h in O-1 mg ml-’ protamine 
sulphate. The positively charged groups of the 
protamine result in a net positive charge in 
the membrane and thus in a negative ion-step 
response. The small negative peak that precedes 
the larger response is a typical boundary potential 
of the membrane while the larger response is 
caused by a proton uptake by titratable groups 
resulting in a temporary increase of the pH in 
the membrane. Experiments showed that already 
after two hours of incubation in 0.1 mg ml-’ 
protamine sulphate, the ion-step response reaches 
a maximum value indicating that the membrane 
is saturated with protamine. Yet the reason for 
incubating the membranes for 15 hours is the 
experience that protamine which was immobilized 
by long incubation times did not desorb at all 
for at least 48 h, while short incubation times 
did result in some desorption of the protamine 
from the polystyrene beads. 
The bottom curve in Fig. 4 represents a typical Ion-step responses were also recorded as a 
ion-step response of an ISFET with a membrane function of pH. Fig. 5 shows the amplitude AV 
(0.12 micron beads) with immobilized protamine. of the ion-step response as a function of pH for 
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Fig. 5. Top curve: amplitude AV of an ion-step response 
of an ISFET with a bare membrane as a function of 
PH. Bottom curves: amplitude AV of ion-step responses 
of six ISFETs with a protamine loaded membrane as 
a function of PH. 
an ISFET with a bare membrane (upper curve, 
typical result) and for a series of six ISFETs 
provided with a protamine loaded membrane 
(lower curves). The pH of the 10 mM KC1 
solution was varied by mixing a citric acid and a 
TRIS buffer solution. The 50 mM KC1 step 
solution was not buffered (pH +5-5) because the 
transient response of the membrane on an ion- 
step is much faster than the establishment of the 
new pH equilibrium in the membrane. 
As a result of the dissociation of titratable 
groups, the charge density in a positively charged 
membrane should decrease with increasing pH 
until the charge density becomes zero at the iso- 
electric point of the charged membrane and then 
changes sign. If the ion-step response should 
only be a function of the charge density, the 
bottom curves in Fig. 5 should continuously rise 
with increasing pH and eventually cross the X- 
axis at the iso-electric point of the membrane. 
This effect is however not seen. The reason for 
this deviation might be that because the ion-step 
response is mainly caused by a release or uptake 
of protons, which result in a temporary pH 
change in the membrane, the buffer capacity of 
the solutions and the membrane also play a very 
important role. Further experiments did indeed 
show a different response when using different 
buffer capacities. More experiments need to be 
done to determine the exact influence of the 
buffer capacity and to interpret the shape of the 
AV-pH curves. Up to now we decided that, in 
order to compare ion-step responses before and 
after modulation of the charge density in the 
membrane, the buffer capacity must be kept 
constant. In a practical application of the sensor, 
the buffer capacity as well as the pH will be kept 
constant before and after modulation of the 
charge in the membrane and only one ion- 
step response is needed (after calibration) to 
determine the concentration. The exact shape 
and nature of the AV-pH curve is then of minor 
importance. 
Each of the six ISFETs with protamine loaded 
membranes was subsequently immersed in a PBS 
solution with a different heparin concentration. 
After 18 and 40 h of incubation, the ion-step 
responses were again recorded as a function of 
pH. In Fig. 6 the amplitudes of the transient 
ion-step responses after 40 h of incubation are 
shown as a function of pH. The shape of the 
AV-pH curves does not significantly change after 
incubation in different heparin solutions. It is 
therefore concluded that the change in the ion- 
step response as a function of heparin concen- 
tration does practically not depend on pH. In 
Fig. 7 we have shown the change in the amplitude 
of the ion-step response at pH 7-4 for the six 
different ISFETs with respect to the response 
before incubation in the heparin solutions. The 
change in the amplitude of the ion-step response 
is plotted as a function of heparin concentration. 
The curves which are fitted through the points 
show a linear relation between the change in 
response and the heparin concentration in the 
range 0.1-1-O units/ml. 
Aiming at a practical application of the sensor, 
incubation times of 18 or 40 h are not very 
auspicious. To determine if more porous mem- 
branes result in shorter incubation times, ISFETs 
were provided with membranes of three different 
sizes of polystyrene beads (O-12, O-43 and l-14 
micron diameter). Protamine was immobilized 
by physical adsorption and the response to 
an ion-step was recorded. The devices were 
subsequently immersed in a PBS solution contain- 
ing O-5 unit/ml heparin and the ion-step response 
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Fig. 6. Amplitude AV of ion-step responses after incu- 
bation for 40 hours in heparin as a function of pH. 
Curve 1 is the average of the sir bottom curves of 
Fig. 5. Curves 2-7 are recorded after incubation in 
respectively O-1, 0.2, 0.4, 0.8, I.6 and 3.2 unit/ml 
heparin in PBS. 
was recorded as a function of incubation time. 
Figure 8 shows the change in the amplitude of 
the ion-step response (with respect o the response 
before incubation in the heparin solution) for 
the different ISFETs as a function of incubation 
time (typical result). From this figure it is obvious 
that larger beads lead to more porous membranes 
and facilitate the diffusion of heparin into the 
membrane. 
Based on these results we decided to use l-14 
micron beads for a new series of devices and 
determine the change in the ion-step response as 
function of a heparin concentration. Protamine 
was again immobilized by physical adsorption 
and before exposing the device to a heparin 
solution, a calibration ion-step response was 
recorded. Figure 9 shows the change of the 
amplitude of the ion-step response after 30, 60 
and 170 min of incubation in the heparin solutions. 
Another series of six ISFETs was provided 
with a membrane of 1-O micron polystyrene beads 
containing functional amino groups. Protamine 
was immobilized by covalent binding via glutaral- 
-0.0 1.0 2.0 3.0 
concentration (Units/ml) 
Fig. 7. Change in amplitude AV of the ion-step 
responses at pH 7.4 as a function of heparin concen- 
tration after 18 h and 40 h of incubation. 
dehyde after which the devices were immersed 
in different heparin solutions. Figure 10 shows 
the results of this experiment. The same type of 
devices were used to determine the ion-step 
response in blood plasma with different heparin 
concentrations. In Fig. 11 the change in the 
amplitude of the ion-step response with respect 
to the response before incubation is shown as 
function of a heparin concentration in blood 
plasma. 
4. DISCUSSION AND CONCLUSION 
The results of the experiments as described in 
the previous section show that it is possible to 
determine heparin concentrations by the ion-step 
measuring method by using protamine as affinity 
ligand. The relation between the change in the 
amplitude of the ion-step response and the 
heparin concentration in PBS can be described 
as linear in the range 0.1-1.0 units/ml. As 
described in the previous section, the measure- 
ments of the different heparin concentrations 
were performed with different devices because 
the ion-step measuring method is a ‘single use’ 
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Fig. 8. Change in amplitude AV of ion-step responses Fig. 9. Change in amplitude AV of ion-step responses 
of ISFETs with protamine loaded membranes of of ISFETs with membranes of I.14 pm polystyrene 
different beads as a function of incubation time in O-5 beads with adsorbed protamine as a function of heparin 
unit/ml heparin. concentration in PBS after three incubation times. 
method. Due to the fabrication process, the 
membrane thickness of the different devices 
varies by about 20%. This is the main reason 
for the individual deviations of the measured 
heparin concentrations from the fitted curve. 
Another fabrication process which controls the 
membrane thickness, for instance spinning the 
membrane mixture on a wafer of ISFETs, will 
reduce these deviations. For higher concen- 
trations and longer incubation times, the curves 
deviate from the linear relation as a result of 
saturation of the membrane with heparin. 
The slope of the response-concentration curve 
is a function of the incubation time, the bead 
diameter and the way of immobilization of 
the protamine. The slope varies from 26 mV 
unit-’ ml-’ for 0.12 micron beads after 40 h of 
incubation to about 3 mV unit-’ ml for 1.0 
micron beads after 15 min of incubation. The 
minimum acceptable slope of the response-con- 
centration curve is determined by the specifi- 
cations for a practical application together with 
the technical specifications of the measurement 
system. If we assume that the required accuracy 
for determining heparin concentrations is O-05 
2 
0 
heparin concentration (Units/ml) 
unit/ml and that the ion-step response is reproduc- 
ible within O-1 mV, the minimum acceptable 
slope is 2 mV unit-’ ml. 
Immobilization of protamine by covalent bind- 
ing results (after a certain incubation time) in a 
larger slope of the response-concentration curve 
than physical adsorption (see Fig. 9 and Fig. 10). 
Covalent coupling by glutaraldehyde results in 
protein binding 6-10 atoms from the surface 
while coupling by adsorption results in protein 
binding on the surface. The covalently coupled 
protamine is therefore better attainable for hep- 
arin than the adsorbed protamine. 
To increase the response after only 15 min of 
incubation, there are a few parameters that still 
can be optimized. The use of larger beads will 
result in more porous membranes which facilitates 
diffusion of heparin in the membranes. However, 
larger beads will give a smaller charge density in 
the membrane which results in a smaller tempor- 
ary pH change in the membrane in response to 
an ion-step. The thickness of the membranes can 
also be reduced to facilitate diffusion of heparin 
in the membrane but this will also result in a 
smaller ion-step response. More experiments 
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Fig. 10. Change in amplitude AV of ion-step responses 
of ISFETs with membranes of 1.0 micron polystyrene 
beads with covalently bound protamine as a function 
of heparin concentration in PBS after two incubation 
times. 
have to be carried out to optimize these two 
parameters. 
The curves in Fig. 11 which represent the 
results of the measurement in blood plasma 
show a significant offset caused by nonspecific 
adsorption of plasma components in the mem- 
brane. To reduce nonspecific adsorption it is 
common practice to block all redundant adsorp- 
tion sites after coupling the affinity ligand. 
This is usually done with albumin or small 
polypeptides. We expect that also in our appli- 
cation, blocking of the adsorption sites will reduce 
the nonspecific adsorption of plasma components. 
The measured relation between the shift in the 
ion-step response and the heparin concentration 
in blood plasma is not linear. It is unclear if this 
is caused by the nonspecific binding of other 
plasma components or that it is caused by the 
binding of plasma proteins to the heparin. More 
experiments will be necessary to determine the 
relation between the ion-step response and the 
heparin concentration in blood plasma. 
The results presented in this paper show the 
possibility of detecting heparin concentrations of 
11 
0.0 0.5 1.0 1.5 2.0 
heparin concentration (Units/ml) 
Fig. 11. Change in amplitude AV of ion-step responses 
of ISFETs with membranes of l-0 micron polystyrene 
beads with covalently bound protamine as a function 
of heparin concentration in blood plasma after two 
incubation times. 
0.1 units/ml using the ion-step measuring method. 
It has been reported that 1 unit of heparin 
corresponds with about 8 microgram for many 
commercial preparations (Jaques et al., 1990). 
The average molecular weight of the heparin 
preparation used is about 15000; thus O-1 unit/ 
ml corresponds with 5 x lo-” Mel/l. This makes 
the ion-step measuring method a very interesting 
method for a broad scale of applications including 
immunodiagnostics. 
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